Repetitive Phrenic Nerve Stimulation in Critically Ill Patients Under Mechanical Ventilation
NCT ID: NCT06491511
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5 participants
OBSERVATIONAL
2024-06-17
2024-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: The study involves performing non-invasive repetitive phrenic nerve stimulation in ICU patients on mechanical ventilation.
Stimulation protocol: The intensity and position of phrenic nerve stimulation were individualized. The frequency was set to 10Hz, 15Hz, and 20Hz. The duration of stimulation was adjusted according to the set inspiration time of mechanical ventilation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcutaneous Repetitive Phrenic Nerve Stimulation in Healthy Adults
NCT05879939
Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial
NCT07133932
tVNS During Motor Training in Older Adults
NCT06323954
Home Operations Utilizing Stimulation
NCT04484285
Transcutaneous Autonomic Modulation in Thoracic Surgery
NCT02783157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU patients
ICU patient with mechanical ventilator
Transcutaneous, repetitive phrenic nerve electrical stimulation
Phrenic nerve electrical stimulation with different stimulation intensity and frequency
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous, repetitive phrenic nerve electrical stimulation
Phrenic nerve electrical stimulation with different stimulation intensity and frequency
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients receiving invasive mechanical ventilation (via endotracheal tube or tracheostomy)
* Patients who have been on invasive mechanical ventilation (via endotracheal tube or tracheostomy) for more than 48 hours
* Patients who have listened to and understood the explanation of the purpose and procedures of the study and have voluntarily agreed to participate. In cases where the patient has impaired consciousness or cognitive function and is unable to consent, the patient's legal representative has agreed to the patient's participation in the study.
Exclusion Criteria
* Patients with a history of neck tumors, cervical spine instability, or neck surgery
* Patients with internal jugular vein catheters, infections, or inflammatory signs at the electrical stimulation site, making percutaneous phrenic nerve access impossible
* Patients with neurological or neuromuscular diseases that significantly affect respiratory muscle function
* Patients currently receiving neuromuscular blocking agents
* Patients already diagnosed with or suspected of having phrenic nerve paralysis
* Patients with elevated hemidiaphragm observed on chest X-ray
* Patients with pleural effusion occupying more than one-third of the pleural space or pneumothorax requiring chest tube insertion, as seen on chest X-ray
* Patients who are confirmed or presumed to be pregnant
* Patients with a body mass index (BMI) ≥ 40
* Patients for whom life-sustaining treatment has been decided to be withdrawn and who have no plans for active treatment
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Foundation of Korea
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sung Eun Hyun
Assistant professor (MD, PhD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sung Eun Hyun, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2312-166-1498
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.